Jennifer Viera | Investor Relations |
Jay Luly | President & Chief Executive Officer |
Paul Mellett | Chief Financial Officer |
Roy Buchanan | JMP Securities |
Rachel Vatnsdal | Piper Sandler |
Brian Skorney | Baird |
Brian Abrahams | RBC Capital Markets |
Jay Olson | Oppenheimer |
Liisa Bayko | Evercore ISI |
Eric Joseph | JPMorgan |
Zegbeh Jallah | ROTH Capital Partners |
Akash Tewari | Wolfe Research |
Good afternoon and welcome to Enanta Pharmaceutical's First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like to turn the conference over to Jennifer Viera Investor Relations.